Effect of cold exposure, exercise and high altitude on plasma endothelin-1 and endothelial cell markers in man

Scottish Medical Journal

Volumn 44, Issue 5, 1999, Pages 143-146

  Cruden, N L M ^b   Newby, D E ^b   Ross, J A ^a   Johnston, N R ^b   Webb, D J ^b  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Cold; Endothelin; Exercise; High altitude; Humans; Selectin; Von Willebrand factor

Indexed keywords

BIG ENDOTHELIN 1; CELL MARKER; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ENDOTHELIN 1; VON WILLEBRAND FACTOR;

ADULT; ALTITUDE; ARTICLE; BLOOD LEVEL; CELL ACTIVATION; COLD EXPOSURE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENVIRONMENTAL TEMPERATURE; EXERCISE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; MALE; MOUNTAINEERING; NORMAL HUMAN;

EID: 0032714176     PISSN: 00369330     EISSN: None     Source Type: Journal    
DOI: 10.1177/003693309904400506     Document Type: Article

References (40)

1. Shore AC. Chapter 2: Vascular biology and physiology. In Tooke JE, Lowe GDO, eds. A Textbook of Vascular Medicine. London, Sydney, Auckland. Arnold, 1996: 742.
2. Haynes WG. and Webb, DJ. The endothelin family of peptides: local hormones with diverse roles in health and disease? Clin Sci 1993; 84: 485-500.
3. Carlos TM and Harlan JM. Leukocyte endothelial adhesion molecules. Blood 1994; 84: 2068-2101.
4. Gearing AJH and Newman W. Circulating adhesion molecules in disease. Immun Today 1993; 14: 506-512.
5. Wagner DD. Cell biology of von Willebrand factor. Ann Rev Cell Biol 1990; 6: 217-46.
6. Hattori R, Hamilton KK, Fugates RD, McEver RP and Sims PJ. Stimulated secretion of endothelial von Willebrand factor is accompanied by rapid redistribution to the cell surface of the intracellular granule membrane protein GMP-140. J Biol Chem 1989; 264: 7768-71.
7. Wagner DD The Wiebel-Palade body: the storage granule for von Willebrand factor and P-selectin. Thromb Haemostas 1993; 70: 105-110.
8. Luffin EG, Fass DN, O'Fallon WM and Bowie EJW. Increased von Willebrand factor in diabetes mellitus. Metabolism 1979; 28: 63-66.
9. Nusinow SR, Federici AB, Zimmerman TS and Curd JG. Increased von Willebrand factor antigen in the plasma of patients with vasculitis. Arthrit Rheum 1984; 27: 1405-1410.
10. Zamora MR, O'Brien RF, Rutherford RB and Weil W. Serum endothelin-1 concentrations and cold provocation in primary Raynaud's phenomenon. Lancet 1990; 336: 1144-47
11. Blann AD, Dobrotova M, Kubisz P and McCollum CN. von Willebrand factor, soluble p-selectin, tissue plasminogen activator and plasminogen activator inhibitor in atherosclerosis. Thromb Haemostas 1995; 74: 626-30.
12. Zeiher AM, Goebel H, Schachinger V and Ihling C. Tissue endothelin-1 immunoreactivity in the active coronary atherosclerotic plaque. Circulation 1995; 91: 941-47.
13. Blann AD, Naqvi T, Waite M and McCollum CN. von Willebrand factor and endothelial damage in essential hypertension. J Hum Hypertens 1993; 7: 107-111.
14. Blann AD, Tse W, Maxwell SRJ and Waite MA. Increased levels of the soluble adhesion molecule E-selectin in essential hypertension. J Hypertens 1994; 12: 925-28.
15. Schifflin EL. Endothelin in hypertension. Curr Opin Cardiol 1995; 10: 485-94.
16. Banks RE, Gearing AM, Hemingway IK, Norfolk DR, Perren U and Selby PJ. Circulating intercellular adhesion molecule-1 (ICAM-1), e-selectin and vascular cell adhesion molecule-1 (VCAM-1) in human malignancies. Br J Cancer 1993; 68: 122-24.
17. Goerre S, Wenk M, Mirtsch P et al. Endothelin-1 in pulmonary hypertension associated with high-altitude exposure. Circulation 1995; 91: 359-64.
18. Morganti A, Giussani M, Sala, C et al. Effects of exposure to high altitude on plasma endothelin-1 levels in normal subjects. J Hypertens 1995; 13: 859-65.
19. Hyers TM, Scoggin CH, Will DH, Grover DH and Reeves H. Accentuated hypoxemia at high altitude in subjects susceptible to high-altitude pulmonary edema. J Appl Physiol 1978; 46: 41-46.
20. Sherrer U, Vollenweider L, Delabays A et al. Inhaled nitric oxide for high altitude pulmonary edema. N Engl J Med 1996; 334: 624-629.
21. Wiinberg N, Walter-Larson S, Eriksen C and Nielsen PE. An evaluation of semiautomatic blood pressure manometers against intra-arterial blood pressure. J Ambulatory Monitoring 1988; 1: 303-309.
22. Rolinski B, Bogner SJ and Goebel FD. Determination of endothelin-1 immunoreaetivity in plasma, cerebrospinal fluid and urine. Res Exp Med 1994; 194: 9-24.
23. Cody RJ, Haas GJ, Binkley P17, Capers Q and Kelley R. Plasma endothelin correlates with the extent of pulmonary hypertension in patients with chronic congestive heart failure. Circulation 1992; 85: 504-509
24. Cejka J. Enzyme immunoassay for factor VIII-related antigen. Clin Chem 1982; 28: 1356-58.
25. Letizia C, Cerci S, De Ciocchis A, D'Ambrosio C, Scuro L and Scavo D. Plasma endothelin-1 levels in normotensive and borderline hypertensive subjects during a standard cold pressor test. J Hum Hypertens 1995; 9: 903-907.
26. Hassi J, Rintamaki H, Ruskaohao H, Lepaluoto J and Vuolteenaho O. Plasma levels of endothelin-1 and atrial natriuretic peptide in men during a 2-hour stay in a cold room. Acta Physiol Scand 1991; 142: 481-485.
27. Hynynen M, Ilmarinen P, Saijonmaa O, Tikkanen I and Fyhrquist F. Plasma endothelin concentration during cold exposure. Lancet 1991; 337: 1104.
28. Hemsen A, Franco-Cereda A, Matran R, Rudehill A and Lundberg JM. Occurrence, specific binding sites and functional effects of endothelin in human cardiopulmonary tissue, Eur J Pharmacol 1990; 191: 319-328.
29. Gasic S, Wagner OF, Vierhapper H, Nowotny P and Waldhausi W. Regional haemodynamic effects and clearance of endothelin-1 in humans: renal and peripheral tissues may contribute to the overall disposal of the peptide. J Cardiovasc Pharmacol 1992; 19: 176-180.
30. Franco-Cereceda A, Barr G, Owall A, Liska J and Lundberg JM. Is endothelin-1 release at reperfusion of the ischaemic human heart due to cold-induced displacement of endothelin from binding sites? Eur J Pharmacol 1995; 279: 105-107.
31. Haynes WG, Ferro CJ, O'Kane KPJ, Somerville D, Lomax CC and Webb DJ. Systemic endothelin receptor blockade decreases peripheral vascular resistance and blood pressure in man. Circulation 1996; 93: 1860-70.
32. Ahlborg G, E Weitzberg and J Lundberg. Metabolic and vascular effects of circulating endothelin-1 during moderately heavy prolonged exercise. J Appl Physiol 1995; 78: 2294-300.
33. Maeda S, Miyauchi T, Katsutoshi G and Matsuda M. Alteration of plasma endothelin-1 by exercise at intensities lower and higher than ventilatory threshold. J Appl Physiol 1994; 77: 1399-1402.
34. Bennet B and Ratnoff OD. Changes in antihemophilic factor (AHF, factor VIII) procoagulant activity and AHF-like antigen in normal pregnancy, and following exercise and pneumoencephalography. J Lab Clin Med 1972; 80: 256-63.
35. Stec JJ, Tofier GH, Lipinska I, Ridker PM and Siegel AL. Exercise induced changes of fibrinolytic and thrombotic potential in runners following the 100th Boston marathon. J Am Coll Cardiol 1997; 29: 156A.
36. Boman K, Hellsten G, Bruce A, Hallmans G and Nilsson TK. Endurance, physical activity, diet and fibrinolysis. Atheroselerosis 1994; 106: 65-74.
37. Haynes WG and Webb DJ. Contribution of endogenous generation of endothelin-1 to basal vascular tone. Lancet 1994; 344: 852-854.
38. Guyton AC. Body temperature, temperature regulation and fever. In Textbook of Medical Physiology. Edited by MJ. Wonsiewicz, Philadelphia, London, Toronto, Montreal, Sydney, Tokyo. W1 I Saunders Company 1991: 797-808.
39. Droma Y, Hayano T, Takabayashi Y et al. Endothelin-1 and interleukin-8 in high altitude pulmonary oedema Eur Resp J 1996; 9: 1947-49
40. Menasche P, Peynet J, Haeffner-Cavaillon N et al. Influence of neutrophil trafficking during clinical liopubnonary bypass. Circulation 1995; 92: H334-H340.